Midurethral minimally invasive sling procedures for stress urinary incontinence.

GUIDELINE TITLE
Midurethral minimally invasive sling procedures for stress urinary incontinence.

BIBLIOGRAPHIC SOURCE(S)
Schulz JA, Chan MC, Farrell SA, Sub-Committee on Urogynaecology. Midurethral minimally invasive sling procedures for stress urinary incontinence. J Obstet Gynaecol Can 2008 Aug;30(8):728-33. [49 references] PubMed

GUIDELINE STATUS
This is the current release of the guideline.

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

October 22, 2008 – Surgical mesh devices: The U.S. Food and Drug Administration (FDA) informed healthcare professionals of serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The FDA provided recommended actions for both physicians and patients to reduce the risks.


abrir aquí para acceder al documento completo:
Midurethral minimally invasive sling procedures for stress urinary incontinence.